Last updated 10 months ago

A Study of Ocrelizumab in Children and Adolescents With Relapsing-Remitting Multiple Sclerosis

36 patients around the world
Available in United States, Mexico
Hoffmann-La Roche
1Research sites
36Patients around the world
This study is for people with
Multiple sclerosis
Pediatric multiple sclerosis
Requirements for the patient
To 18 Years
All Gender
Medical requirements
Sites
Clinstile S.A de C.V.
Recruiting
Durango 325, Roma Norte, Ciudad de México
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy